Moreover, kynurenine aminotransferase 2 (KAT2), which convert kynurenine into kynurenic acid (KYNA), was manifested with higher expression level in cluster 1, suggesting protective effects of KYNA in glioma. This evidence concerns the gene AADAT and central nervous system cancer.